Depression and anxiety in psoriatic disease: Prevalence and associated factors

Journal of Rheumatology

Volumn 41, Issue 5, 2014, Pages 887-896

  McDonough, Emily ^a   Ayearst, Renise ^c   Eder, Lihi ^b   Chandran, Vinod ^b   Rosen, Cheryl F ^a   Thavaneswaran, Arane ^b   Gladman, Dafna D ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Anxiety; Depression; Disease activity; Hospital anxiety and depression scale; Psoriatic arthritis

Indexed keywords

ADULT; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HEALTH SURVEY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL DISABILITY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SEX DIFFERENCE; SHORT FORM 36; UNEMPLOYMENT; AGED; ANXIETY DISORDERS; ARTHRITIS, PSORIATIC; DAILY LIFE ACTIVITY; DEPRESSIVE DISORDER; DISABILITY; MIDDLE AGED; OUTCOME ASSESSMENT; PSYCHOLOGY; RISK FACTOR;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANXIETY DISORDERS; ARTHRITIS, PSORIATIC; DEPRESSIVE DISORDER; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS;

EID: 84899758219     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130797     Document Type: Article

References (47)

1. Griffiths CE, Barker JM. Pathogenesis and clinical features of psoriasis. Lancet 2007;370:263-71 (Pubitemid 47069537)
2. Myers WA, Gottlieb AB, Mease P. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms. Clin Dermatol 2006;24:438-47 (Pubitemid 44332869)
3. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005;64 Suppl 2:18-25
4. Gladman DD. Psoriatic arthritis. Dermatol Ther 2009;22:40-55
5. Biljan D, Laufer D, Filakovic P, Situm M, Brataljenovic T. Psoriasis, mental disorders and stress. Coll Antropol 2009; 33:889-92
6. Akay A, Pekcanlar A, Bozdag KE, Altintas L, Karaman A. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002;16:347-52 (Pubitemid 34918815)
7. Schmitt JM, Ford DE. Role of depression in quality of life for patients with psoriasis. Dermatology 2007;215:17-27 (Pubitemid 46976010)
8. Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S. An Italian study on psoriasis and depression. Dermatology 2006;212:123-7 (Pubitemid 43260727)
9. Richards HL, Fortune DG, Griffiths CE, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001;50:11-5 (Pubitemid 32279929)
10. Zimmerman M, Lish JD, Lush DT, Farber NJ, Plescia G, Kuzma MA. Suicidal ideation among urban medical outpatients. J Gen Intern Med 1995;10:573-6
11. Cooper-Patrick L, Crum RM, Ford DE. Identifying suicidal ideation in general medical patients. JAMA 1994;272:1757-62 (Pubitemid 24372003)
12. Olfson M, Weissman MM, Leon AC, Sheehan DV, Farber L. Suicidal ideation in primary care. J Gen Intern Med 1996; 11:447-53 (Pubitemid 26299144)
13. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:846-50 (Pubitemid 28520293)
14. Rosen CF, Mussani F, Chandran V, Eder L, Thavaneswaran A, Gladman DD. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology 2012;51:571-6
15. Harvima RJ, Viinamaki H, Harvima IT, Naukkarinen A, Savolainen L, Aalto ML, et al. Association of psychic stress with clinical severity and symptoms of psoriatic patients. Acta Derm Venereol 1996;76:467-71 (Pubitemid 26398097)
16. Isik A, Koca SS, Ozturk A, Mermi O. Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 2007;26:872-8 (Pubitemid 46951281)
17. Freire M, Rodriguez J, Moller I, Valcarcel A, Tornero C, Diaz G, et al. Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics [Spanish]. Reumatol Clin 2011;7:20-6
18. Khraishi M, MacDonald D, Rampakakis E, Vaillancourt J, Sampalis JS. Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts. Clin Rheumatol 2011; 30:877-85
19. Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 2011;63:1729-35
20. Kotsis K, Voulgari PV, Tsifetaki N, Machado MO, Carvalho AF, Creed F, et al. Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res 2012;64:1593-601
21. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983;67:361-70 (Pubitemid 13098606)
22. Taylor W, Gladman DD, Helliwell PS, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73 (Pubitemid 44205029)
23. Gladman DD, Chandran V. Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology 2011;50:25-31
24. Lewis G, Wessely S. Comparison of the General Health Questionnaire and the Hospital Anxiety and Depression Scale. Br J Psychiatry 1990;157:860-4
25. Strik JJ, Honig A, Lousberg R, Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001;42:423-8 (Pubitemid 33032115)
26. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA)-an analysis of 220 patients. Q J Med 1987;62:127-41 (Pubitemid 17042878)
27. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72
28. Marks R, Barton SP, Shuttleworth D, Finlay AY. Assessment of disease progress in psoriasis. Arch Dermatol 1989;125:235-40 (Pubitemid 19070211)
29. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-44 (Pubitemid 8387357)
30. Mackenzie H, Thavaneswaran A, Chandran V, Gladman DD. Patient-reported outcome in psoriatic arthritis: a comparison of Web-based versus paper-completed questionnaires. J Rheumatol 2011;38:2619-24
31. Husted JA, Gladman DD, Farewell VT, Cook R. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Care Res 2001; 45:151-8 (Pubitemid 32954441)
32. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28:1842-6 (Pubitemid 32726931)
33. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83
34. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45 (Pubitemid 10164318)
35. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6 (Pubitemid 24194579)
36. Blackmore M, Gladman DD, Husted J, Long J, Farewell VT. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol 1995;22:886-93
37. Husted J, Gladman DD, Long JA, Farewell VT, Cook R. Validating the SF-36 health questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511-7 (Pubitemid 27153417)
38. Current depression among adults - United States, 2006 and 2008. MMWR Morb Mortal Wkly Rep 2010;59:1229-35
39. Murphy LB, Sacks JJ, Brady TJ, Hootman JM, Chapman DP. Anxiety and depression among US adults with arthritis: prevalence and correlates. Arthritis Care Res 2012;64:968-76
40. Bandinelli F, Prignano F, Bonciani D, Pallanti S, Lotti T, Salaffi F, et al. Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA). Clin Exp Rheumatol 2013;31:318-9
41. El-Miedany YM, El Rasheed AH. Is anxiety a more common disorder than depression in rheumatoid arthritis? Joint Bone Spine 2002;69:300-6 (Pubitemid 34654365)
42. Schmitt J, Ford DE. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - a structural equations modeling approach. Gen Hosp Psychiatry 2007;29:134-40
43. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989;20:53-63 (Pubitemid 19033846)
44. O'Brien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 2004;19:397-403 (Pubitemid 39172804)
45. Patarca R, Klimas NG, Lugtendorf S, Antoni M, Fletcher MA. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 1994;18 Suppl 1:S147-53 (Pubitemid 24023903)
46. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006;367:29-35 (Pubitemid 43038667)
47. Carroll CL, Feldman SR, Camacho FT, Balkrishnan R. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 2004;151:895-7. (Pubitemid 39482127)